Diabetic Retinopathy 1 Symposium

Related

• 

  Outcomes of Patients with DME and Baseline BCVA 20/50 or Worse or 20/40 or Better Treated with Aflibercept 8 mg and 2 mg in the Phase 2/3 PHOTON Trial

  Diana V Do, MD, FASRS

  Updates from the Field

  2024

• 

  Relationship between Change in Visual Acuity and Change in Retinal Thickness during Treatment of Diabetic Macular Edema with Anti-VEGF

  Daniel F. Rosberger, MD, PhD, MPH

  On Demand Cases, Courses, and Papers

  2019

• 

  Bimanual Vitrectomy for Diabetic Tractional Retinal Detachment

  Rohit Adyanthaya, MD

  Innovative Retina Surgical Video Series

  2017